Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Serap B. Sahin, Teslime Ayaz, Medine C. Cure, Hacer Sezgin, Ulku M. Ural, Gulsah Balik & Figen K. Sahin. (2014) Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome. Scandinavian Journal of Clinical and Laboratory Investigation 74:6, pages 465-469.
Read now
Read now
Articles from other publishers (34)
Aikaterini Giannouli, Charikleia Stefanaki, Christos Kouskoutis, Marianna Konidari, Iliana Mani, Konstantina Konidari, Sophia L. Markantonis, Aimilia Mantzou, Spyridon P. Dourakis, Efthymios Deligeoroglou & Flora Bacopoulou. (2023) Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study. Journal of Clinical Medicine 12:17, pages 5744.
Crossref
Crossref
Yamei Hu, Junjie Xu, Sheng jie Shi, Xiaoge Zhou, Liguang Wang, Liang Huang, Lei Gao, Weijun Pang, Gongshe Yang & Guiyan Chu. (2022) Fibroblast growth factor 21 (FGF21) promotes porcine granulosa cell estradiol production and proliferation via PI3K/AKT/mTOR signaling. Theriogenology 194, pages 1-12.
Crossref
Crossref
Susanne Schüler-Toprak, Olaf Ortmann, Christa Buechler & Oliver Treeck. (2022) The Complex Roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis. Biomedicines 10:10, pages 2503.
Crossref
Crossref
Jennie L. YoostMorgan RuleyKia SmithNalini SantanamHolly A. Cyphert. (2022) Diagnostic Value of Bile Acids and Fibroblast Growth Factor 21 in Women with Polycystic Ovary Syndrome. Women's Health Reports 3:1, pages 803-812.
Crossref
Crossref
Xiawen Yu, Yue Xia, Jue Jia & Guoyue Yuan. (2022) The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis. Frontiers in Endocrinology 13.
Crossref
Crossref
Guillaume Bourdon, Anthony Estienne, Claire Chevaleyre, Christelle Ramé, Fabrice Guérif, Jean-Sébastien Brun, Claudine Vasseur, Gaelle Fromont, Ingrid Plotton, Diane Dufour-Rainfray, Erika Caldas-Silveira, Joëlle Dupont, Pascal Froment & Pierre-Henri Ducluzeau. (2022) The Hepatokine FGF21 Increases the Human Spermatozoa Motility. Frontiers in Endocrinology 13.
Crossref
Crossref
Carmen Emanuela Georgescu. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
187
216
.
Alécia A. Oliveira-Santos, Roberto Salvatori, Ana C. Bueno, Monica C. Nogueira, Viviane C. Campos, Manuela A. Melo, Carla R. P. Oliveira, Cynthia S. Barros-Oliveira, Cindi G. Marinho, Nayra P. Damascena, Elenilde G. Santos, Enaldo V. Melo, Francisco J. A. de Paula, Margaret de Castro & Manuel H. Aguiar-Oliveira. (2021) Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency. Endocrine 73:1, pages 160-165.
Crossref
Crossref
Katarzyna J. Siemienowicz, Klaudia Furmanska, Panagiotis Filis, Chiara Talia, Jennifer Thomas, Paul A. Fowler, Mick T. Rae & W. Colin Duncan. (2021) Pubertal FGF21 deficit is central in the metabolic pathophysiology of an ovine model of polycystic ovary syndrome. Molecular and Cellular Endocrinology 525, pages 111196.
Crossref
Crossref
Andrew Tannous, Andrew P. Bradford, Katherine Kuhn, Angela Fought, Irene Schauer & Nanette Santoro. (2021) A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome. PLOS ONE 16:3, pages e0247638.
Crossref
Crossref
Sylwia Bednarska, Jolanta Fryczak & Agnieszka Siejka. (2020) Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome. Cytokine 134, pages 155188.
Crossref
Crossref
Manjunath Ramanjaneya, Milin Bensila, Ilham Bettahi, Jayakumar Jerobin, Tareq A. Samra, Myint Myint Aye, Meis Alkasem, Kodappully Sivaraman Siveen, Thozhukat Sathyapalan, Monica Skarulis, Stephen Lawrence Atkin & Abdul-Badi Abou-Samra. (2020) Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women. Frontiers in Endocrinology 11.
Crossref
Crossref
Ting Xie & Po Sing Leung. (2020) Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases. Journal of Pancreatology 3:1, pages 29-34.
Crossref
Crossref
Xiaolong Yuan, Shaopan Ye, Zitao Chen, Xiangchun Pan, Shuwen Huang, Zhonghui Li, Yuyi Zhong, Ning Gao, Hao Zhang, Jiaqi Li & Zhe Zhang. (2019) Dynamic DNA methylation of ovaries during pubertal transition in gilts. BMC Genomics 20:1.
Crossref
Crossref
M. Rodgers, B. Heineman & J. Dushay. (2019) Increased fructose consumption has sex‐specific effects on fibroblast growth factor 21 levels in humans. Obesity Science & Practice 5:5, pages 503-510.
Crossref
Crossref
A. Migdal, S. Comte, M. Rodgers, B. Heineman, E. M. Flier, M. Herman & J. Dushay. (2018) Fibroblast growth factor 21 and fructose dynamics in humans. Obesity Science & Practice 4:5, pages 483-489.
Crossref
Crossref
Nazanin Moslehi, Sakineh Shab-Bidar, Fahimeh Ramezani Tehrani, Parvin Mirmiran & Fereidoun Azizi. (2018) Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause 25:9, pages 1046-1055.
Crossref
Crossref
S. Kahraman, A. E. Altinova, M. M. Yalcin, O. Gulbahar, B. Arslan, M. Akturk, N. Cakir & F. B. Toruner. (2018) Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome. Journal of Endocrinological Investigation 41:9, pages 1069-1074.
Crossref
Crossref
Ting Xie & Po Sing Leung. (2017) Fibroblast growth factor 21: a regulator of metabolic disease and health span. American Journal of Physiology-Endocrinology and Metabolism 313:3, pages E292-E302.
Crossref
Crossref
Tao Hu, Xiaoxue Yuan, Rongcai Ye, Huiqiao Zhou, Jun Lin, Chuanhai Zhang, Hanlin Zhang, Gang Wei, Meng Dong, Yuanyuan Huang, Wonchung Lim, Qingsong Liu, Hyuek Jong Lee & Wanzhu Jin. (2017) Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat. The Journal of Nutritional Biochemistry 47, pages 21-28.
Crossref
Crossref
Murat Akyol, Ahmet Alacacioglu, Leyla Demir, Yuksel Kucukzeybek, Yasar Yildiz, Zehra Gumus, Mete Kara, Tarik Salman, Umut Varol, Halil Taskaynatan, Utku Oflazoglu, Vedat Bayoglu & Mustafa Oktay Tarhan. (2017) The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy. Cancer Biomarkers 18:4, pages 441-449.
Crossref
Crossref
Konstanze Miehle, Thomas Ebert, Susan Kralisch, Annett Hoffmann, Jürgen Kratzsch, Haiko Schlögl, Michael Stumvoll & Mathias Fasshauer. (2016) Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy. Cytokine 83, pages 239-244.
Crossref
Crossref
M. Díaz, J.M. Gallego-Escuredo, F. de Zegher, F. Villarroya & L. Ibáñez. (2016) Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess. Diabetes & Metabolism 42:3, pages 196-199.
Crossref
Crossref
Leila Bagheri, Maryam Hami, Mohammad-Javad Mojahedi, Mahin Ghorban Sabbagh & Hosein Ayatollahi. (2016) Association of metabolic syndrome with serum fibroblast growth factor 21 in kidney transplanted patients. Journal of Renal Injury Prevention 5:2, pages 79-84.
Crossref
Crossref
Xiaoyan Zhang, Yanyun Hu, Hui Zeng, Lianxi Li, Jungong Zhao, Jun Zhao, Fang Liu, Yuqian Bao & Weiping Jia. (2015) Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients. Cardiovascular Diabetology 14:1.
Crossref
Crossref
C. H. Lee, E. Y. L. Hui, Y. C. Woo, C. Y. Yeung, W. S. Chow, M. M. A. Yuen, C. H. Y. Fong, A. Xu & K. S. L. Lam. (2015) Circulating Fibroblast Growth Factor 21 Levels Predict Progressive Kidney Disease in Subjects With Type 2 Diabetes and Normoalbuminuria. The Journal of Clinical Endocrinology & Metabolism 100:4, pages 1368-1375.
Crossref
Crossref
Magdalena Olszanecka-Glinianowicz, Paweł Madej, Michał Wdowczyk, Aleksander Owczarek & Jerzy Chudek. (2015) Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome. European Journal of Endocrinology 172:2, pages 173-179.
Crossref
Crossref
Vibha Singhal, Elizabeth A. Lawson, Kathryn E. Ackerman, Pouneh K. Fazeli, Hannah Clarke, Hang Lee, Kamryn Eddy, Dean A. Marengi, Nicholas P. Derrico, Mary L. Bouxsein & Madhusmita Misra. (2014) Irisin Levels Are Lower in Young Amenorrheic Athletes Compared with Eumenorrheic Athletes and Non-Athletes and Are Associated with Bone Density and Strength Estimates. PLoS ONE 9:6, pages e100218.
Crossref
Crossref
Yun Shen, Xiaojing Ma, Jian Zhou, Xiaoping Pan, Yaping Hao, Mi Zhou, Zhigang Lu, Meifang Gao, Yuqian Bao & Weiping Jia. (2013) Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. Cardiovascular Diabetology 12:1.
Crossref
Crossref
Holger Stepan, Karoline Kley, Janka Hindricks, Susan Kralisch, Alexander Jank, Wiebke Schaarschmidt, Susanne Schrey, Thomas Ebert, Ulrike Lössner, Jürgen Kratzsch, Matthias Blüher, Michael Stumvoll, Judit Richter & Mathias Fasshauer. (2013) Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine 62:2, pages 322-326.
Crossref
Crossref
Y. C. Woo, Aimin Xu, Yu Wang & Karen S. L. Lam. (2013) Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives. Clinical Endocrinology 78:4, pages 489-496.
Crossref
Crossref
Wen Guo, Siu Wong, Michelle Li, Wentao Liang, Marc Liesa, Carlo Serra, Ravi Jasuja, Andrzej Bartke, James L. Kirkland, Orian Shirihai & Shalender Bhasin. (2012) Testosterone Plus Low-Intensity Physical Training in Late Life Improves Functional Performance, Skeletal Muscle Mitochondrial Biogenesis, and Mitochondrial Quality Control in Male Mice. PLoS ONE 7:12, pages e51180.
Crossref
Crossref
Pedro Iglesias, Rafael Selgas, Sara Romero & Juan J Díez. (2012) MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. European Journal of Endocrinology 167:3, pages 301-309.
Crossref
Crossref
Susan Kralisch & Mathias Fasshauer. (2011) Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease. Current Opinion in Clinical Nutrition and Metabolic Care 14:4, pages 354-359.
Crossref
Crossref